cGxP.wire https://validator.w3.org/feed/docs/rss2.html Cepheid Gains IVDR CE Mark for Respiratory Panel Curia Expands Precision Fermentation Capacity in Spain Boehringer’s SCOVELLA Gains Positive EU Opinion Alnylam Reports Five-Year AMVUTTRA Benefits in ATTR-CM Eilean Reports First Human MALT1 Degradation Alphyn’s Zabalafin Highlighted in Atopic Dermatitis Review Biond Biologics Doses First Patient in BND-67 Trial HotSpot Therapeutics Reports HST-2011 Preclinical Data Protalix Reports 12-Week Uric Acid Control With PRX-115 Pierre Fabre and XtalPi Partner in AI Drug Discovery UCB Reports Sustained BIMZELX Responses in Psoriatic Arthritis Bayer Wins FDA Approval for Asundexian in Stroke Prevention Boehringer Reports Positive Survodutide Phase III Data Merck Reports Positive Efinopegdutide MASH Trial Data Valneva Reports 94% IXCHIQ Antibody Response at Five Years Actinium Forms Scientific Board to Guide Cancer Pipeline Aisa Pharma Reports Positive Phase II Data for AISA-021 Caris Reveals ESR1 Mutation Insights in Breast Cancer AbelZeta Reports CAR-T Data in Advanced Liver Cancer Lilly’s Foundayo Shows Positive Phase III Sleep Apnea Data ACP and OpenEvidence Partner to Advance Clinical AI Amgen Highlights Earlier Repatha Use at AHA 2026 OrthoTrophix Reports TPX-100 Data in Knee Osteoarthritis SetPoint Medical Reports 24-Month RA Treatment Data Ribo Files EU Phase I Trial for Dual-Targeting SR122 GlycoNex Submits Denosumab Biosimilar SPD8 in Japan InnoCare Advances Mesutoclax in Phase III AML Trial Regeneron’s CIDEB siRNA Cuts Liver Fat in Early Trial Vir Biotechnology Phase 3 Trial Meets Hepatitis Delta Goal BMS Reports 56-Week CAMZYOS Data in Pediatric oHCM Lilac Biosciences Appoints Adriana Coll De Peña as CEO AusperBio Reports 15-Month Hepatitis B Cure With AHB-137 Brii Bio Reports Phase 2 Progress in Hepatitis B Cure ImmunoGenesis Highlights IMGS-203 in Two Cancer Studies Skyhawk Doses First U.S. Patients in Huntington’s Trial Elysium Expands Peptide Access and Launches Research Programs Servier Expands Glioma Portfolio With New Cancer Data Bausch Health’s Salix Highlights Severe Alcohol-Associated Hepatitis Burden Antengene Unveils AnTenGager-D2 Preclinical Cancer Data Innovent Reports Phase 3 Tafolecimab Success in Lipids Novo Reports Wegovy Liver Marker Gains in Adults With MASH Allergan Reports Facial Satisfaction Gains Among GLP-1 Users J&J Reports 73% PSA Response in Advanced Prostate Cancer NYU Langone: Heart Procedures Show No Long-Term Survival Benefit Inimmune Reports Phase 1 INI-4001 Results for Solid Tumors Thermo Fisher Launches AmpSure Universal qPCR Master Mixes Biohaven Advances Pivotal Phase 3 Trial for Graves’ Disease Nuvo REACTIVE Trial Shows Gains in At-Home Fetal Monitoring Amgen Reports 20% Lower Heart Attack Risk With Repatha Zydus Reports Positive Phase 2b Saroglitazar MASH Data